CTE granted executive stock options on January 1, 2018, that permit executives to purchase 20 million of the company’s $1 par common shares within the next 8 years, but not before December 31, 2021 (vesting date). The exercise price is the market price of the shares on the date of grant, which is $11 per share. The Fair value of options, estimated by an appropriate option pricing model, is $4 per option. No forfeitures are anticipated. Half of the options are exercised on April 15th 2022, when the market price is $25 per share.
By what amount will CTE’s paid in capital- excess of par be increased by on date of exercise?
140 million
280 million
160 million
100 million
Ans is A | 140 Million | |||
Explanation | ||||
Total compensation expenses | 20 M x $4 | =80M | ||
On exercise following entry to be recorded | ||||
Cash (10,000,000 X $11) | $ 110,000,000 | |||
Paid-in Capital—Stock Options | $ 40,000,000 | |||
($80M X 1/2) | ||||
Common Stock (10 M X $1) | $ 10,000,000 | |||
Paid-in Capital in Excess of Par | $ 140,000,000 | |||
(To record issuance of 10M | ||||
shares of $1 par value stock | ||||
upon exercise of options at | ||||
option price of $11) | ||||
Get Answers For Free
Most questions answered within 1 hours.